scispace - formally typeset
I

In Soo Kim

Researcher at Chungnam National University

Publications -  18
Citations -  358

In Soo Kim is an academic researcher from Chungnam National University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 4, co-authored 9 publications receiving 185 citations.

Papers
More filters
Journal ArticleDOI

COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis.

TL;DR: It is reported here that toll-like receptor (TLR) 4-mediated inflammatory signaling molecules are upregulated in peripheral blood mononuclear cells from COVID-19 patients, compared with healthy controls (HC).
Journal ArticleDOI

MIR144* inhibits antimicrobial responses against Mycobacterium tuberculosis in human monocytes and macrophages by targeting the autophagy protein DRAM2

TL;DR: This study shows that Mtb significantly induces the expression of MIR144*/hsa-miR-144-5p, which targets the 3′-untranslated region of DRAM2 (DNA damage regulated autophagy modulator 2) in human monocytes and macrophages, and reveals that DR AM2 is a key coordinator of autophagic activation that enhances antimicrobial activity against Mtb.
Journal ArticleDOI

Vitamin D-Cathelicidin Axis: at the Crossroads between Protective Immunity and Pathological Inflammation during Infection.

TL;DR: Recent findings that demonstrate how the vitamin D-cathelicidin pathway regulates autophagy machinery, protective immune defenses, and inflammation, and contributes to immune cooperation between innate and adaptive immunity are discussed.
Journal ArticleDOI

MiR-144-3p is associated with pathological inflammation in patients infected with Mycobacteroides abscessus.

TL;DR: In this article, the authors investigated the characteristic immune profiles of peripheral blood mononuclear cells (PBMCs) from patients infected with Mycobacteroides abscessus subsp. massiliense (Mmass) and found that several inflammatory cytokines/chemokines [interleukin (IL)-1β, IL-6, C-X-C motif chemokine ligand 2] and miR-144-3p were significantly upregulated in PBMCs from patients compared with those from healthy controls (HCs).